Investor Carl Icahn appears to be giving up on his attempts to takeover Clorox (NYSE:CLX).
Late Friday, Icahn said in a regulatory filing his group was withdrawing its attempt to put a total of 11 people on Clorox's board, including Icahn himself.
Clorox has rejected takeover several bids from Icahn, the latest totaling $80 per share, saying the offers were not credible, and undervalued the company.
Icahn has also suggested that Clorox would be a good takeover target for strategic buyers like Procter & Gamble (NYSE:PG) or Kimberly Clark (NYSE:KMB).
Icahn abandoned similar activist investment moves at Lions Gate Entertainment (NYSE:LGF) and Forest Laboratories (NYSE:FRX) over the summer.
Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes
only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners.
In no way should any content contained herein be interpreted to represent trading or investment advice.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.